Thanks for this; I especially appreciate therapists’ takes on using these medicines in the clinical setting. (Especially when they’re as open-hearted and open-minded as this.)

That said, a couple of notes:

1. You make reference to trying to check in with patients post-session, which is admirable and correct. But I would suggest that it’s in the integration stage — the days and weeks post-session — that the work truly happens. While it’s tempting to prioritize the fireworks (even the low-Watt ones) one experiences during the medicine session, equal or greater weight has to be given to what happens later, in that liminal period in which the insights and perspective can best be worked into everyday life / consensus reality / whatever you choose to call it.
2. I’m curious about lose-dose MDMA. I’m certainly not an expert, but my understanding is that the minimum threshold (depending on several factors) is roughly 70mg, and often much higher. In other words, even given that, in theory, micro-dosing anything is supposed to be largely subperceptual, it’s especially difficult to micro-dose MDMA and experience useful effects.